Unicycive Therapeutics, Inc. (UNCY)
7.60
+0.22
(+2.98%)
USD |
NASDAQ |
Jun 01, 16:00
7.75
+0.15
(+1.97%)
After-Hours: 16:56
Unicycive Therapeutics Total Assets (Quarterly) : 64.41M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.605B |
| Gilead Sciences, Inc. | 56.28B |
| Alnylam Pharmaceuticals, Inc. | 5.130B |
| Anika Therapeutics, Inc. | 179.39M |
| Savara, Inc. | 221.64M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 26.70M |
| Shareholders Equity (Quarterly) | 37.70M |
| Debt to Equity Ratio | 0.025 |
| Current Ratio | 2.399 |
| Net Debt Paydown Yield | -0.02% |